We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should Investors Buy JPMorgan Stock Ahead of Q3 Earnings?
Read MoreHide Full Article
JPMorgan Chase (JPM - Free Report) will kickstart third quarter results from big banks this week as investors look for insight into the effect rate cuts will have on the broader banking industry.
To that point, banks can experience benefits and drawbacks from interest rate cuts with loan demands likely to rise although profit margins might decrease.
That said, let’s see if it’s time to buy JPMorgan’s stock ahead of its Q3 earnings report on Friday.
JPM Q3 Expectations
Based on Zacks estimates, JPMorgan’s Q3 sales are expected to be up 3% to $41.01 billion. However, Q3 earnings are thought to have decreased 7% to $4.02 per share versus EPS of $4.33 in the prior-year quarter.
Notably, JPMorgan has surpassed the Zacks EPS Consensus for eight consecutive quarters posting an average earnings surprise of 8.38% in its last four quarterly reports.
Find the latest EPS estimates and surprises on ZacksEarnings Calendar.
Image Source: Zacks Investment Research
JPM’s Earnings Estimate Outlook
Looking forward, JPMorgan’s top line is now projected to expand 9% in fiscal 2024 to $172.47 billion although FY25 sales are expected to dip -2%.
On the bottom line, 3% EPS growth is expected in FY24 with annual earnings forecasted to be virtually flat next year at $16.72 per share.
Image Source: Zacks Investment Research
JPM’s Stock Performance & Valuation
Attributed to its strong market position and financial performance, JPMorgan’s stock has risen over +20% year to date which has edged the benchmark S&P 500 and big bank peers Bank of America (BAC - Free Report) , Citigroup (C - Free Report) , and Wells Fargo (WFC - Free Report) .
Image Source: Zacks Investment Research
Despite soaring over +100% in the last two years, JPM still trades at 12.6X forward earnings and roughly on par with Bank of America, and their Zacks Banks-Major Regional Industry average. JPM does trade at a slight earnings premium to Wells Fargo and Citigroup but is at a significant discount to the benchmark’s 24.1X forward P/E multiple.
Image Source: Zacks Investment Research
Bottom Line
Ahead of its Q3 report, JPMorgan’s stock lands a Zacks Rank #3 (Hold). While it will be important to monitor JPMorgan’s profit margins amid a deflationary environment, holding on to JPM at current levels could certainly be rewarding.
Furthermore, there could be more upside in JPM if the banking giant can reach or exceed Q3 expectations and quite any probability fears while giving a positive outlook especially as it pertains to higher loan volumes.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Should Investors Buy JPMorgan Stock Ahead of Q3 Earnings?
JPMorgan Chase (JPM - Free Report) will kickstart third quarter results from big banks this week as investors look for insight into the effect rate cuts will have on the broader banking industry.
To that point, banks can experience benefits and drawbacks from interest rate cuts with loan demands likely to rise although profit margins might decrease.
That said, let’s see if it’s time to buy JPMorgan’s stock ahead of its Q3 earnings report on Friday.
JPM Q3 Expectations
Based on Zacks estimates, JPMorgan’s Q3 sales are expected to be up 3% to $41.01 billion. However, Q3 earnings are thought to have decreased 7% to $4.02 per share versus EPS of $4.33 in the prior-year quarter.
Notably, JPMorgan has surpassed the Zacks EPS Consensus for eight consecutive quarters posting an average earnings surprise of 8.38% in its last four quarterly reports.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Image Source: Zacks Investment Research
JPM’s Earnings Estimate Outlook
Looking forward, JPMorgan’s top line is now projected to expand 9% in fiscal 2024 to $172.47 billion although FY25 sales are expected to dip -2%.
On the bottom line, 3% EPS growth is expected in FY24 with annual earnings forecasted to be virtually flat next year at $16.72 per share.
Image Source: Zacks Investment Research
JPM’s Stock Performance & Valuation
Attributed to its strong market position and financial performance, JPMorgan’s stock has risen over +20% year to date which has edged the benchmark S&P 500 and big bank peers Bank of America (BAC - Free Report) , Citigroup (C - Free Report) , and Wells Fargo (WFC - Free Report) .
Image Source: Zacks Investment Research
Despite soaring over +100% in the last two years, JPM still trades at 12.6X forward earnings and roughly on par with Bank of America, and their Zacks Banks-Major Regional Industry average. JPM does trade at a slight earnings premium to Wells Fargo and Citigroup but is at a significant discount to the benchmark’s 24.1X forward P/E multiple.
Image Source: Zacks Investment Research
Bottom Line
Ahead of its Q3 report, JPMorgan’s stock lands a Zacks Rank #3 (Hold). While it will be important to monitor JPMorgan’s profit margins amid a deflationary environment, holding on to JPM at current levels could certainly be rewarding.
Furthermore, there could be more upside in JPM if the banking giant can reach or exceed Q3 expectations and quite any probability fears while giving a positive outlook especially as it pertains to higher loan volumes.